11 Newly-Listed NASDAQ Stocks to Buy Now

Page 2 of 10

9. Heartflow, Inc. (NASDAQ:HTFL)

On February 12, 2026, Heartflow, Inc. (NASDAQ:HTFL) announced an expansion of its GAMEFILM Registry. Initially focused on retired National Football League athletes, the study will now include former players from the National Basketball Association and the National Hockey League, broadening the initiative to additional professional sports. Chief Executive Officer John Farquhar said, “Expanding our GAMEFILM Registry to include NBA and NHL athletes marks a pivotal moment for Heartflow,” adding that the company’s diagnostic capabilities are intended to support athlete health and generate insights for cardiovascular care.

In late January 2026, Wells Fargo initiated coverage of Heartflow, Inc. (NASDAQ:HTFL) with an Overweight rating and a $38 price target. Wells Fargo cited upside to Street estimates driven by the company’s fractional flow reserve-computed tomography and plaque volume analyses. Wells Fargo described Heartflow, Inc. (NASDAQ:HTFL) as having a “strong first mover advantage” in software and AI-based diagnosis and management of coronary artery disease and expects approximately 20% growth over the next three years, supported by its FFRCT and plaque offerings.

Heartflow, Inc. (NASDAQ:HTFL) is a medical technology company that provides non-invasive solutions for diagnosing and managing coronary artery disease using AI and computational fluid dynamics to create personalized 3D heart models from coronary CT scans.

Page 2 of 10